BioCentury
ARTICLE | Company News

Icos, Protarga deal

August 5, 2002 7:00 AM UTC

The companies partnered to develop new small molecule anti-cancer drug candidates. Under the deal, Protarga will use its Targaceutical natural fatty acid-based targeting technology against ICOS's prec...